Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
TRAWthis companyTraws Pharma, Inc.	$0.25	1.36×	-14.78×	3.33×	-0.31×	-2461.3%	100.0%	-640.7%	328.7%	-1457.9%	3379.0%	-223.4%	0×	0.21×	0×	0.72×	0.0%	1	-117.77	2	B-
BOLTBolt Biotherapeutics, Inc.	$6.35	-0.31×	0.39×	1.33×	-0.67×	-1476.7%	80.6%	-450.1%	-433.7%	-125.9%	-67.7%	-390.3%	0.87×	-0.35×	0×	3.59×	0.0%	2	-18.11	2	C
BRTXBioRestorative Therapies, Inc.	$1.55	-0.75×	29.75×	29.5×	-0.65×	-3282.4%	93.4%	-4350.1%	-3959.4%	-3992.2%	-4386.1%	-102.8%	0×	0.11×	0×	0.84×	0.0%	2	-58.36	2	C+
CINGCingulate Inc.	$4.40	-1.05×	9.4×	0×	-1.1×	-99.0%	0.0%	0.0%	0.0%	-894.8%	-176.5%	-73.8%	3.5×	0.11×	-21.57×	1.16×	0.0%	2	-3.41	2	C
COCPCocrystal Pharma, Inc.	$1.05	-1.26×	1.75×	0×	-0.65×	-55.3%	0.0%	0.0%	0.0%	-139.5%	-115.1%	-74.2%	0.24×	0.65×	0×	3.68×	0.0%	3	-108.13	1	C-
DWTXDogwood Therapeutics, Inc.	$1.17	-0.96×	0.46×	0×	-0.82×	-43.2%	0.0%	0.0%	0.0%	-45.7%	-32.1%	-45.7%	0×	0.19×	0×	2.76×	0.0%	1	-1.2	3	B
Peer median	—	-0.96×	1.75×	0×	-0.67×	-99.0%	0.0%	0.0%	0.0%	-139.5%	-115.1%	-74.2%	0.24×	0.11×	0×	2.76×	0.0%	2	-18.11	2	—